Details for Patent: 10,588,988

Which drugs does patent 10,588,988 protect, and when does it expire?

Patent 10,588,988 protects DEFINITY and DEFINITY RT and is included in one NDA.

This patent has twenty-six patent family members in fourteen countries.

Summary for Patent: 10,588,988

Title:	Methods and devices for preparation of ultrasound contrast agents
Abstract:	Provided herein are methods and devices for identifying and/or distinguishing UCA formulations and specifically activating such formulations to produce UCA suitable for in vivo use.
Inventor(s):	Simon P. Robinson, Carol Walker, David C. Onthank, Joel Lazewatsky, Nhung Tuyet Nguyen
Assignee:	Lantheus Medical Imaging Inc
Application Number:	US16/559,528
Patent Claim Types: see list of patent claims	Use; Formulation; Device;

Drugs Protected by US Patent 10,588,988

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Lantheus Medcl	DEFINITY	perflutren	INJECTABLE;INTRAVENOUS	021064-001	Jul 31, 2001		RX	Yes	Yes						METHOD OF USING THE DRUG SUBSTANCE/DRUG PRODUCT FOR ULTRASOUND IMAGING
Lantheus Medcl	DEFINITY RT	perflutren	INJECTABLE;INTRAVENOUS	021064-002	Nov 17, 2020		RX	Yes	Yes						METHOD OF USING THE DRUG SUBSTANCE/DRUG PRODUCT FOR ULTRASOUND IMAGING

International Family Members for US Patent 10,588,988

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2017260532
Australia	2024266778
Brazil	112018072342
Canada	3022698
China	109641068